Search

everythinglearnresearchcommunity

for

Search:↓

Thorough scalp exams are crucial for diagnosing hair loss conditions in people with skin of color.

Idiopathic chronic telogen effluvium in women causes sudden hair loss without a known cause, often linked to emotional distress.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

Midscalp hair density and terminal hair percentage are good indicators of female pattern hair loss severity.

Trichoscopy is an effective, noninvasive method for early diagnosis of Female Pattern Hair Loss.

Different types of female pattern hair loss have unique characteristics and are associated with various health conditions.

More personalized and effective treatments for androgenetic alopecia are needed.

Higher levels of the protein Pannexin-1 may play a role in hair loss in women with PCOS.

COVID-19 may cause temporary hair loss in some people.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

Monocytes might be linked to hair loss after COVID-19.

Women with female pattern hair loss may have a higher risk of metabolic syndrome.

The emu oil emulsion with minoxidil was better at promoting hair growth than the commercial product.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

15.33% of young Caucasian men have severe hair loss, with higher rates in Jewish men and links to age, BMI, and possibly metabolic syndrome.

Trichoscopy, a hair loss evaluation technique, found that people with Androgenetic Alopecia have more thin hairs, yellow dots, and perifollicular discoloration than healthy individuals.

Androgenetic alopecia negatively affects self-esteem and daily stress, especially in young men.

Both 5% minoxidil foam and liquid effectively treat hair loss, with foam slightly preferred.

Current and new treatments for hair loss include topical minoxidil and oral finasteride, but results vary and new options are being explored.

Retinoids may improve hair growth in androgenic alopecia when used with other treatments.

Both treatments improved hair quality and thickness equally, with mild side effects.

Hair loss in men and women can be treated with medications and therapies, showing improvement after 6 months.

A woman's increased facial hair and hair loss were caused by a rare ovarian tumor, cured by surgery.

Some types of hair loss can be reversed, others are permanent, and treatments vary by type.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

Stress, hypothyroidism, drug intake, and anemia are important factors in women's diffuse hair loss.

Androgenetic alopecia may be irreversible due to the detachment of a muscle from hair follicles.

People with early-onset androgenetic alopecia may have a higher risk of heart disease due to abnormal blood lipid levels.

Most patients with hair loss sought treatment for cosmetic reasons, were unhappy about their appearance, and had a family history of the condition, suggesting it may be inherited.

Injectable treatments can effectively and safely improve hair growth in adults with androgenetic alopecia.